Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Channel Policy Frustrations into Advocacy to Improve Patient Care

Leslie Mertz, PhD  |  Issue: June 2021  |  April 2, 2021

As a fellow in training, Howard Yang, MD, RhMSUS, became frustrated with certain policy issues he viewed as obstacles to providing timely, optimal care for patients. Rather than simply grumbling about it, he accepted an ACR invitation to channel those feelings into action and became an advocate for rheumatology. It was such an eye-opening and rewarding experience that Dr. Yang, now a practicing rheumatologist at UCLA Health’s Santa Monica and Ronald Reagan Medical Centers, encourages other up-and-coming professionals to think about how they can get involved and make a real difference in the field.

Howard Yang

Dr. Howard Yang

Dr. Yang recently took some time from his busy schedule to discuss his advocacy efforts—and why such work is critical—with The Rheumatologist.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The Rheumatologist (TR): Why did you decide to get involved with advocacy?

Dr. Yang: While I was still a fellow in training, I started to see things that needed changing. For example, I wanted to use certain medications, but the insurance [company] would reject [my prescriptions], and I couldn’t understand why. I was told that’s just the way it is, but I thought, ‘This is not right.’ And then I got an email from the ACR asking if I would be interested in advocacy. I did not even know what advocacy was at that point, but I replied, ‘Sure. I want to learn.’

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

TR: What happened next?

Dr. Yang: The ACR brought me to Washington, D.C., and I got to speak to rheumatologists and other fellows in training, as well as patients, nurses, physical therapists and pharmacists. It was quite a humbling experience learning the lingo and how our government works. I mean, we’ve all seen the cartoon about how a bill turns into a law, but this showed me what all goes into that and what happens afterward, and it introduced me to the Centers for Medicare & Medicaid Services and the U.S. Department of Health & Human Services and their roles.

Once I was fortunate enough to join the ACR’s Government Affairs Committee (GAC), I learned that advocacy is about looking at a larger issue and finding those specific parts that are the problem, such as the amount of time rheumatologists have to spend filling out insurance paperwork or calling for prior authorization. Once you identify those parts, we can then figure out how to change them.

TR: How are you helping effect change as an advocate?

Page: 1 2 | Single Page
Share: 

Filed under:Uncategorized Tagged with:AdvocacyGovernment Affairs Committee (GAC)Howard Yang

Related Articles

    The 2021 ACR Awards of Distinction & Distinguished Fellows

    December 16, 2021

    During ACR Convergence 2021 in early November, the ACR honored a group of individuals who have made significant contributions to rheumatology research, education and patient care, announcing the recipients of the ACR’s 2021 Awards of Distinction, as well as the group of Distinguished Fellows. recognized for their contributions. Three pediatric rheumatologists and one pediatric fellow…

    The American College of Rheumatology (ACR) can Help Combat Insurance Frustrations

    April 6, 2012

    When it comes to dealing with insurance companies, the rules seem to change frequently and always in an arbitrary and capricious way. The ACR is trying its best to protect rheumatologists, but we need your help!

    2017 ACR/ARHP Honors & Awards, Part 2

    January 19, 2018

    SAN DIEGO—At the 2017 ACR/ARHP Annual Meeting in San Diego in November, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the ARHP winners about their individual contributions. In addition, we profile the new class…

    How to Launch Successful Rheumatology Patient Advocacy Programs

    July 14, 2015

    Editor’s note: This is the second installment of a two-part series showing how a busy office-based practice can incorporate patient advocacy into its standard workflow. In Part 1, we looked at the reasons for incorporating patient advocacy into your practice and offered an outline for implementing it. Part 2 amplifies the concepts explored in Part…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences